Search research articles
Contact Us
Filters
Showing results (151-160 of 184) with videos related to
Page
of 19
Sort By:
Haematologica
|
January 30, 2025
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trial
Margot S F Roeten, Johan Van Meerloo, Suzanne N Van Dijk, et al.
Journal of Hematology & Oncology
|
September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
Denise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.
Frontiers in Immunology
|
March 14, 2022
Activation of LXR Nuclear Receptors Impairs the Anti-Inflammatory Gene and Functional Profile of M-CSF-Dependent Human Monocyte-Derived Macrophages
Arturo González de la Aleja, Cristina Herrero, Mónica Torres-Torresano, et al.
Arthritis and Rheumatism
|
February 28, 2009
Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide
Joost W van der Heijden, Ruud Oerlemans, Paul P Tak, et al.
Leukemia
|
May 18, 2021
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
Inge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Leukemia
|
July 17, 2021
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
Inge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Arthritis Research & Therapy
|
March 5, 2013
Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis
Yoony Y J Gent, Karin Weijers, Carla F M Molthoff, et al.
International Journal of Biological Sciences
|
June 21, 2024
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target
Rocco Sciarrillo, Francesca Terrana, Annalisa Comandatore, et al.
Frontiers in Immunology
|
February 21, 2022
Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis
Maarten M Steinz, Aiarpi Ezdoglian, Fatemeh Khodadust, et al.
Haematologica
|
September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors
Denise Niewerth, Niels E Franke, Gerrit Jansen, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 184) with videos related to
Sort By:
Page
of 19
Haematologica
|
January 30, 2025
High immunoproteasome and low constitutive proteasome subunit levels correlate with sensitivity to bortezomib-containing chemotherapy: update from the Children's Oncology Group AALL1231 trial
Margot S F Roeten, Johan Van Meerloo, Suzanne N Van Dijk, et al.
Journal of Hematology & Oncology
|
September 8, 2016
Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
Denise Niewerth, Gertjan J L Kaspers, Gerrit Jansen, et al.
Frontiers in Immunology
|
March 14, 2022
Activation of LXR Nuclear Receptors Impairs the Anti-Inflammatory Gene and Functional Profile of M-CSF-Dependent Human Monocyte-Derived Macrophages
Arturo González de la Aleja, Cristina Herrero, Mónica Torres-Torresano, et al.
Arthritis and Rheumatism
|
February 28, 2009
Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide
Joost W van der Heijden, Ruud Oerlemans, Paul P Tak, et al.
Leukemia
|
May 18, 2021
SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
Inge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Leukemia
|
July 17, 2021
Author Correction: SF3B1 as therapeutic target in FLT3/ITD positive acute myeloid leukemia
Inge van der Werf, Anna Wojtuszkiewicz, Huilan Yao, et al.
Arthritis Research & Therapy
|
March 5, 2013
Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis
Yoony Y J Gent, Karin Weijers, Carla F M Molthoff, et al.
International Journal of Biological Sciences
|
June 21, 2024
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target
Rocco Sciarrillo, Francesca Terrana, Annalisa Comandatore, et al.
Frontiers in Immunology
|
February 21, 2022
Folate Receptor Beta for Macrophage Imaging in Rheumatoid Arthritis
Maarten M Steinz, Aiarpi Ezdoglian, Fatemeh Khodadust, et al.
Haematologica
|
September 24, 2013
Higher ratio immune versus constitutive proteasome level as novel indicator of sensitivity of pediatric acute leukemia cells to proteasome inhibitors
Denise Niewerth, Niels E Franke, Gerrit Jansen, et al.
Page
of 19